Valuation: Navamedic ASA

Market Cap 393M 40.59M 35.62M 33.17M 30.51M 57.19M 3.88B 58.17M 394M 154M 1.92B 152M 149M 6.64B P/E 2026 *
-298x
P/E 2027 * 36.9x
Enterprise Value 513M 52.98M 46.49M 43.29M 39.82M 74.64M 5.06B 75.92M 514M 201M 2.51B 199M 195M 8.67B EV / Sales 2026 *
0.87x
EV / Sales 2027 * 0.75x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 day+0.92%
1 week+4.46%
Current month+0.31%
1 month+0.61%
3 months-15.03%
6 months-24.77%
Current year-31.09%
1 week 15.9
Extreme 15.9
16.95
1 month 15.7
Extreme 15.7
17.45
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 2018-12-31
Director of Finance/CFO - 2025-12-31
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 2022-05-31
Director/Board Member - 2023-05-31
Director/Board Member 60 2024-05-31
Date Insider Type Main position Quantity % Market Cap.
12/19/24 Buy

Chief Operating Officer

10,267 0.0581%
9/9/24 Fiscal year

Chief Executive Officer

80,000 0.4589%
9/9/24 Fiscal year

Executive/Senior Manager

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+0.92%+4.46%-31.38%-55.19% 40.33M
+1.93%+3.85%+51.05%+166.24% 1,068B
+0.29%+6.43%+60.47%+52.87% 641B
+2.45%+2.77%+39.61%+74.48% 454B
+2.17%+10.22%+41.17%+36.56% 351B
+1.46%+3.87%+39.70%+44.49% 299B
+0.40%+3.59%+19.93%+17.02% 266B
+2.73%+3.50%-25.66%-36.53% 220B
+4.48%+7.33%+30.47%+66.31% 203B
+2.91%+3.10%+18.84%+74.76% 162B
Average +2.06%+4.18%+24.42%+44.10% 366.34B
Weighted average by Cap. +1.96%+4.79%+39.98%+80.09%

Financials

2026 *2027 *
Net sales 588M 60.67M 53.24M 49.58M 45.6M 85.49M 5.8B 86.95M 588M 230M 2.87B 228M 223M 9.93B 643M 66.41M 58.28M 54.27M 49.92M 93.57M 6.34B 95.18M 644M 252M 3.15B 249M 244M 10.87B
Net income -1.5M -154K -135K -126K -116K -217K -14.74M -221K -1.5M -586K -7.31M -579K -567K -25.26M 10.7M 1.1M 969K 902K 830K 1.56M 106M 1.58M 10.71M 4.19M 52.32M 4.15M 4.06M 181M
Net Debt 120M 12.38M 10.87M 10.12M 9.31M 17.45M 1.18B 17.75M 120M 47M 587M 46.49M 45.49M 2.03B 87.4M 9.02M 7.92M 7.37M 6.78M 12.71M 862M 12.93M 87.45M 34.23M 427M 33.86M 33.13M 1.48B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
26-07-28 NOK 16.40 +0.92% 986
26-07-27 NOK 16.25 -0.91% 4,905
26-07-24 NOK 16.40 +1.23% 9,916
26-07-23 NOK 16.20 +0.31% 1,900
26-07-22 NOK 16.15 +2.87% 12,620
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.40NOK
Average target price
23.50NOK
Spread / Average Target
+43.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock